Focal Cerebral Arteriopathy Steroid Trial

PHASE4Enrolling by invitationINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

July 31, 2029

Study Completion Date

January 31, 2030

Conditions
Pediatric StrokeArteriopathyArterial Ischemic Stroke
Interventions
DRUG

methylprednisolone, prednisolone, prednisone

Any generic or brand-name methylprednisolone at the appropriate dose may be used. Likewise, any generic or brand-name prednisolone, or prednisone, at the appropriate dose may be used.

Trial Locations (1)

94158

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

University of Cincinnati

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

M.D. Anderson Cancer Center

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Iowa

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

collaborator

American Heart Association

OTHER

lead

University of California, San Francisco

OTHER